Hypoglycemia–if taken with sulphonylureas or insulin Thrush Urinary Tract Infections Increased urination Pain when urinating Changes in levels of blood fats Blood pressure lowering
Conditions Category: SGLT2I
In recent trials of SGLT2i treatments, mortality was reduce for all-cause and cardiovascular death in patients with heart failure with reduced ejection fraction and a reduction in hospital admissions. Kidney function also improved. These medications are now available for people with heart failure with reduced ejection fraction, with or without type 2 diabetes.
SGLT2i (Gliflozins) medication stands for Sodium-glucose co-transporter-2 and can lower the glucose (sugar) levels in the blood